MedPath

Vancomycin Hydrochloride

Vancomycin Hydrochloride for Injection, USP(For Intravenous Use)

Approved
Approval ID

a5f2ede4-8dd0-97c6-e556-2a80f78c10c4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 14, 2023

Manufacturers
FDA

Almaject, Inc.

DUNS: 116626205

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

vancomycin hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72611-765
Application NumberANDA205694
Product Classification
M
Marketing Category
C73584
G
Generic Name
vancomycin hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 29, 2016
FDA Product Classification

INGREDIENTS (1)

vancomycin hydrochlorideActive
Quantity: 1 g in 20 mL
Code: 71WO621TJD
Classification: ACTIM

vancomycin hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72611-761
Application NumberANDA205694
Product Classification
M
Marketing Category
C73584
G
Generic Name
vancomycin hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 29, 2016
FDA Product Classification

INGREDIENTS (1)

vancomycin hydrochlorideActive
Quantity: 500 mg in 10 mL
Code: 71WO621TJD
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vancomycin Hydrochloride - FDA Drug Approval Details